Highlights and Quick Summary
- Trade and Non-Trade Receivables Growth for the quarter ending February 28, 2023 was 0.34 (a 228.78% increase compared to previous quarter)
- Year-over-year quarterly Trade and Non-Trade Receivables Growth decreased by -64.87%
- Annual Trade and Non-Trade Receivables Growth for 2022 was 1.1 (a 260.84% increase from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2021 was 0.3 (a -2568.29% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2020 was -0.01 (a -100.34% decrease from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Trade and Non-Trade Receivables Growth of Organigram Holdings Inc.
Most recent Trade and Non-Trade Receivables Growthof OGI including historical data for past 10 years.Interactive Chart of Trade and Non-Trade Receivables Growth of Organigram Holdings Inc.
Organigram Holdings Inc. Trade and Non-Trade Receivables Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.34 | – | – | – | – |
| 2022 | 0.1 | 1.17 | 0.98 | 0.9 | 1.1 |
| 2021 | 0.82 | 0.33 | 0.48 | -0.4 | 0.3 |
| 2020 | -0.27 | -0.04 | -0.33 | -0.23 | -0.01 |
| 2019 | 0.4 | 3.5 | 0.49 | 0.3 | 3.57 |
| 2018 | – | – | -0.29 | -0.78 | -0.1 |
| 2017 | – | – | – | – | 1.69 |
| 2016 | – | – | – | – | -0.63 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic